The IL-6/JAK/STAT signaling pathway is involved in the pathogenesis of various inflammatory and autoimmune diseases, and JAK inhibitors are emerging as promising new therapeutics for the treatment of autoimmune diseases40. The gene discussed is IL6; the disease is autoimmune disease.